The ongoing debate over reclassifying cannabis from Schedule I to Schedule III under the Controlled Substances Act is a pivotal...
The ongoing debate over reclassifying cannabis from Schedule I to Schedule III under the Controlled Substances Act is a pivotal...
The ongoing debate over reclassifying cannabis from Schedule I to Schedule III under the Controlled Substances Act is a pivotal...
The ongoing debate over reclassifying cannabis from Schedule I to Schedule III under the Controlled Substances Act is a pivotal...
The ongoing debate over reclassifying cannabis from Schedule I to Schedule III under the Controlled Substances Act is a pivotal...
The ongoing debate over reclassifying cannabis from Schedule I to Schedule III under the Controlled Substances Act is a pivotal...
The ongoing debate over reclassifying cannabis from Schedule I to Schedule III under the Controlled Substances Act is a pivotal...
Feb 26, 2024 New research released by DCC also finds 62% of Californians believe Proposition 64 has had a...
In episode 136 we speak with Dentons European cannabis lead, Peter Homberg, out of Berlin, about the recently passed legislation...
Green Thumb Industries Inc. (CSE: GTII) (OTCQX: GTBIF) reported its earnings late Wednesday, revealing significant financial achievements for the fourth...